Contributing Author

Andrew J Cutler

3 articles in Psychopharmacology Bulletin

Serotonergic Drugs for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Review of Past Development, Pitfalls and Failures, and a Look to the Future

Craig Chepke, Elizabeth Brunner, Andrew J Cutler

VOL 54 No. 4 GENERAL PSYCHIATRY

A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812

Azmi Nasser, Tesfaye Liranso, Toyin Adewole, Nicholas Fry, Joseph T. Hull, Fatima Chowdhry, Gregory D. Busse, Zare Melyan, Andrew J. Cutler, Robert L. Findling, Stefan Schwabe

VOL 51 No. 2 ORIGINAL RESEARCH

Read Article

A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned

Andrew J. Cutler, Tram Tran-Johnson, Amir Kalali, Mikael Åström, Martin Brecher, Didier Meulien

VOL 43 No. 4 NEGATIVE AND FAILED CLINICAL TRIAL RESULTS

Read Article